CACNA1H and glioblastoma: More recently, small hairpin RNA (shRNA)-mediated silencing of CaV3.2 or mibefradil treatment was shown to inhibit the proliferation, survival and stemness features of glioblastoma stem-like cells (GSC) as well as sensitize them to temozolomide chemotherapy [49].